A Service For Professionals Tuesday, November 21, 2017
Contact (202) 540-8337
Company News Today
A Service For Professionals Tuesday, November 21, 2017 11614 Sources 416,877,379 Articles 3,022,490 Readers
Contact (202) 540-8337

Oculus Innovative Sciences Announces Fiscal First Quarter 2017 Financial Results and Conference Call

/EIN News/ -- PETALUMA, Calif., July 19, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal first quarter 2017, ended June 30, 2016, will be released after the U.S. markets close on July 28, 2016. The earnings release will be followed by a conference call at 1:30 p.m. PDT on July 28, 2016, to discuss fiscal first quarter results.

Individuals interested in participating in the conference call may do so by dialing 877-303-7607 for domestic callers or 973-638-3203 for international callers.  Those interested in listening to the conference call live via the internet may do so at http://ir.oculusis.com/events.cfm. Please log on approximately 30 minutes prior to the presentation in order to register and download the appropriate software.

A telephone replay will be available for seven days following the conclusion of the call by dialing 855-859-2056 for domestic callers, or 404-537-3406 for international callers, and entering conference code 46082115. A webcast replay will be available on the site at http://ir.oculusis.com/events.cfm for one year following the call.

About Oculus Innovative Sciences, Inc.
Oculus Innovative Sciences is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at oculusis.com.

Media and Investor Contact:
                    
                    Oculus Innovative Sciences, Inc.
                    
                    Dan McFadden
                    VP of Public and Investor Relations
                    (425) 753-2105
                    dmcfadden@oculusis.com

Primary Logo

Powered by EIN News